Kindly MD, Inc.’s Post

In this episode of #AlternativeRealities is all about investing in the future of healthcare. What are the biggest breakthroughs? And where are the most attractive investment opportunities? Find out as Dr. David Kelly, Chief Global Strategist and his guest Gaurav Gupta, Managing Partner of Life Science Private Capital within J.P. Morgan Private Capital, share their latest insights: https://bit.ly/3CAItdR

In this episode of #AlternativeRealities is all about investing in the future of healthcare. What are the biggest breakthroughs? And where are the most attractive investment opportunities? Find out as Dr. David Kelly, Chief Global Strategist and his guest Gaurav Gupta, Managing Partner of Life Science Private Capital within J.P. Morgan Private Capital, share their latest insights: https://bit.ly/3NWyWjE

📈 Sophie Smith, our talented Investment Analyst for the SGH Medical Technology and Emerging Companies Funds, shares her stock picks at the small end of the Australian healthcare market with Tom Richardson at The Australian Financial Review. 👇 👇 👇 Check out which companies she backs and why here: https://lnkd.in/gaQDJwKn #medtech #ASX #ASXSmallCompanies #equityinvesting

Tammy Ward Woffenden and I are very much looking forward to this timely discussion. Please join us for this complimentary webinar on health care deal making!

Earlier this year, Michael Hodges (Managing Director – Capital Markets, Christie & Co) sat down with Patrick Ryan (Principal, SIRE Capital Partners) to discuss key investment opportunities in the UK healthcare market. To hear the full conversation, click here: https://lnkd.in/e9RrXVDe #capitalmarkets #healthcareinvestment #commercialproperty

Sometimes holidays make you realise how small and interconnected our planet is… Great insights shared by my PE-focused colleagues in Chicago, with valuable resonance in EMEA markets. Their emphasis on the themes underpinning investing in Healthcare assets - highlights global trends that transcend geos. Thanks Ropes & Gray LLP Chicago #PrivateEquity #HealthcareInvesting #GlobalTrends

📈 The life sciences and health care industry is undergoing a series of significant sector-level transformations that are fundamentally changing the basis of competition and driving the continued reassembly of the industry. “To win amidst these dynamics, private equity firms and their portfolio companies will need to embrace a platform-centric business model that can create exponential value for its ecosystem.” 📊 Read more 👉 https://lnkd.in/es_uTxK5

Over the last few weeks, I have discussed how I expect a big year in Australia's Life Science companies in 2025. In this Executive Interview, Hashan De Silva, CFA, Founder and Managing Partner of KPRX, a specialist healthcare VC firm, shares his insights into the unique advantages of the Australian and New Zealand healthcare sectors. https://lnkd.in/eR48W-4E

Big trends are shaking up the healthcare sector! Dive into the latest insights on global M&A and private equity, and discover the strategies shaping the future of healthcare investments. Curious about what’s next? 📈💡https://okt.to/tviAwl

Early-stage healthcare ventures hold the power to transform lives, yet they often struggle to gain the financial support needed to scale. How can we bridge this gap? At NLC, our Investment Director Lars Olthof and the team are focused on reshaping the early-stage healthcare investment landscape—unlocking opportunities that drive both societal impact and financial returns. Curious about the strategies driving this transformation? 👉 Swipe through the carousel to learn more, and click the link in the comments to read the full article by Lars. #HealthcareInnovation #ImpactInvesting #VentureCapital #HealthcareSolutions #EarlyStageInvesting